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The effect of the injection site on the pharmacokinetics of phenol red and bromphenol blue 
as model drugs after intraperitoneal (i.p.) administration into rats was examined.   Their 
absorption rate from the peritoneal cavity was faster after i.p. administration to the liver 
surface (LS) than that after i.p. administration to the distal small intestine (SI), as shown by 
the increase in maximum concentration and decrease in mean residence time in plasma.   
A similar tendency was observed in the biliary excretion pattern.   The enhanced 
absorption rate was supported by the significantly smaller amount of both drugs remaining 
in the peritoneal cavity at 15 min after LS administration than that after SI administration.   
The liver concentration of the model drugs at 15 min after LS administration was 1.5 - 2.0 
times higher than that after SI administration.   Accordingly, LS administration was 
shown to be effective with good absorbability and efficient drug delivery to the liver. 
 
 2
In the chemotherapy of a localized tumor in the liver, direct drug injection to the liver has 
been suggested to enhance local drug distribution (Mattijssen et al 1992; Dubinett et al 
1993; Balemans et al 1993).   On the other hand, regional drug application to the organ 
surface via the intraperitoneal (i.p.) route may be advantageous for organ-specific drug 
delivery, particularly to the liver.   However, the differences in the drug absorption from 
the peritoneal cavity with the injection site have not been elucidated fully.   In the present 
study, we examined the effects of i.p. injection site on absorption of two organic anions 
(phenol red and bromphenol blue) as model drugs. 
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Materials and Methods 
Chemicals 
Phenol red and bromphenol blue were purchased from Nacalai Tesque, Inc. (Kyoto, Japan).    
All other chemicals were of reagent grade. 
 
In-vivo experiment 
All animal procedures in the present study conformed to the Guideline for Animal 
Experimentation in Nagasaki University. 
   Male Wistar rats, 230-250 g, were anaesthetized with sodium pentobarbitone (50 mg  
kg-1, i.m.), and the left femoral artery was cannulated with a polyethylene tube (i.d. 0.5 mm, 
o.d. 0.8 mm, Dural Plastics, Dural, Australia).   An incision of approximately 2 cm was 
made in the middle abdomen and the common bile duct was cannulated with a polyethylene 
tube (i.d. 0.28 mm, o.d. 0.61 mm, Becton Dickinson & Co., Parsippany, NJ, U.S.A.).   
Phenol red (2 or 6 mg) or bromphenol blue (2 mg) in an isotonic phosphate buffer (pH 7.4) 
(0.2 mL) was administered i.p. to the area of either the liver surface (LS) or distal small 
intestine (SI).   The injection point of LS administration was the division between the 
right and left lobe.   The drug solution was i.p. administered to SI, 5 cm below the 
injection point of LS. 
   After application of the drug solution, 200 µL blood was collected at selected times 
from the heparinized cannula inserted into the femoral artery over 4 h.   Blood was 
centrifuged at 15000 rev-1 min-1 for 5 min.   Bile samples were collected at appropriate 
time intervals for 4 h.   In another experiments, the drug solution remaining in the 
peritoneal cavity was withdrawn by washing with saline at 15 or 60 min after dosing, and 
then the liver was excised. 
Analytical method 
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The concentrations of model drugs in plasma, bile and remaining solution in the peritoneal 
cavity were determined. 
   The concentration of free phenol red was determined spectrophotometrically at 560 nm 
after dilution with 1 M NaOH.   The total concentration of free phenol red and its 
metabolite was measured in the same manner after the samples were subjected to acid 
hydrolysis (1 M HCl at 100°C for 30 min) (Hart & Schanker 1966).   The concentration 
of phenol red metabolite was estimated from the difference between these values. 
   The concentration of bromphenol blue was determined spectrophotometrically at 591 
nm after dilution with isotonic phosphate buffer (pH 7.4) (Takada et al 1974). 
   The concentration of the model drug in the liver was determined as follows.   The 
excised liver was homogenized in threefold of its weight of distilled water and of pH 6.5 
phosphate buffer for analysis of phenol red and bromphenol blue, respectively.   After 5 
mL of acetone was added to 5 mL of the liver homogenate, the mixture was shaken for 15 
min, followed by centrifugation for 15 min at 3000 rev-1 min-1.   The concentration of the 
drug in the resulting supernatant was determined in the same manner as described above. 
 
Calculation of moment parameters 
The moment parameters for the plasma concentration profile of free phenol red and 
bromphenol blue (AUCp, MRTp) and those for biliary excretion rate-time curves of free 
phenol red and bromphenol blue (AUCb,f, MRTb,f), and of the phenol red metabolite 
(AUCb,m, MRTb,m) were calculated by numeral integration using a linear trapezoidal 
formula and extrapolation to infinite time based on a monoexponential equation (Yamaoka 
et al., 1978). 
Results and Discussion 
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I.p. administration has been extensively applied to treatment of the cancer restricted to the 
peritoneal cavity such as ovarian carcinoma, and is considered to be an effective method for 
organ-specific drug delivery, owing to ease of regional delivery of a drug to the target site. 
   The main purpose of this study is to examine the difference in pharmacokinetics after 
i.p. administration of the drug by the injection site.   We selected phenol red and 
bromphenol blue as model drugs, because their in-vivo absorbability after application to rat 
liver surface employing a glass cell were previously determined (Nishida et al 1994, 1995). 
< Fig.1 > 
   Figs 1a and 1b show the plasma concentration profiles of phenol red (2 or 6 mg) and 
bromphenol blue (2 mg), respectively, after their i.p. administration to the area around the 
LS or SI in rats.   I.p. administered phenol red appeared in the plasma with a peak level 
during 30 min after dosing, followed by gradual disappearance.   The plasma 
concentration of phenol red after LS administration was higher than that after SI 
administration up to 60 min, and its maximum concentration (Cmax) was increased.   On 
the other hand, the plasma concentration profile of bromphenol blue after LS administration 
reached a peak at 5 min.   In this case, the Cmax value after LS administration was 3.3 
times that after SI administration.   These findings suggest the increased absorption from 
the peritoneal cavity around the LS in rats. 
< Fig.2 > 
   Figs 2a-c illustrate the biliary excretion rate-time curves of free phenol red and its 
metabolite, and bromphenol blue after LS or SI administration of phenol red and 
bromphenol blue.   During the first 60 min after LS administration, the biliary excretion 
of both drugs was more rapid than that after SI administration.   This observation can be 
explained by the increased peritoneal absorption rate. 
<Table 1> 
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   The overall absorption process can be evaluated with moment parameters.   In 
particular, AUCp and MRTp are useful parameters for roughly evaluating the drug 
absorbability from the peritoneal cavity.   Table 1 summarizes the moment parameters for 
phenol red and bromphenol blue after LS or SI administration into rats. 
   The AUCp values for both drugs after LS administration were larger than those after SI 
administration, although less markedly for phenol red.   The difference of MRTp values 
between i.p. and i.v. administration corresponds to the mean time value for the absorption 
from the peritoneal cavity (MAT).   MRTp after i.v. administration of phenol red at a dose 
of 2 or 6 mg, and bromphenol blue were calculated to be 43.7, 43.6 and 9.5 min, 
respectively (our unpublished data).   As shown in Table 1, the MAT values for both 
drugs were shortened considerably by LS administration, the reduction being marked for 
bromphenol blue. 
   With respect to biliary excretion, the MRTb,f for both drugs after LS administration was 
shorter than that after SI administration.   The AUCb,m value for phenol red was increased 
by LS administration, suggesting that its metabolism is affected by the injection site. 
<Table 2> 
   Table 2 shows the level of phenol red and bromphenol blue in the peritoneal cavity and 
liver at 15 and 60 min after LS or SI administration 
   The amount remaining in the peritoneal cavity after LS administration was smaller than 
that after SI administration for both drugs, although the difference was not significant for 
bromphenol blue at 60 min.   This supports the high absorption of these model drugs from 
the peritoneal cavity around the LS. 
   The liver concentrations of phenol red and bromphenol blue at 15 min after LS 
administration were 1.5 - 2.0 times higher than those after SI administration, which 
suggests that LS administration enhances drug delivery to the liver. 
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   The effects of molecular weight (Dedrick et al 1978; Litterst et al 1982), charge (Lukas 
et al 1971), and injection volume (Barrett et al 1991; Bredberg et al 1994) on the drug 
absorption after i.p. administration have been reported.   In contrast, the present study 
provides the evidence of a difference in pharmacokinetics after i.p. administration with the 
injection site.   However, the mechanism underlying this phenomenon is not clear. 
   Previously (Nishida et al 1994, 1995), we examined the in-vivo behaviour of model 
drugs after application to LS in rats, using a cylindrical glass cell (i.d. 9 mm; area 0.64 cm2), 
to clarify drug absorption from the liver-surface membrane.   The absorption rates of 
phenol red and bromphenol blue at 6 h were relatively high (91.8 and 71.6 % of dose, 
respectively).   The difference in the peritoneal absorption of model drugs with the 
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Legends for figures 
 
FIG. 1.   Plasma concentration profiles of phenol red (a) at a dose of 2 (circle) or 6 mg 
(triangle), and bromphenol blue (b) (dose: 2 mg) (circle) after LS (closed symbol) or SI 
(open symbol) administration.   Values are means ± s.e. of at least three experiments. 
 
FIG. 2.   Biliary excretion rate-time curves for free phenol red (circle) and its metabolite 
(triangle) at a dose of 2 (a) or 6 mg (b), and bromphenol blue (c) (dose: 2 mg) (circle) after 
LS (closed symbol) or SI (open symbol) administration.   Values are means ± s.e. of at 
least three experiments. 
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Table 1. Moment parameters for plasma concentration and biliary excretion rate-time 
curves for free phenol red and its metabolite, and bromphenol blue after LS or SI 
dministration in rats. a
 
 Phenol red (2 mg) Phenol red (6 mg) Bromphenol blue (2 mg)  
 Parameter SI LS SI LS SI LS 
 
 AUCp 1443.9 1533.6 3255.5 3663.7 224.5 433.9* 
 (µg min mL-1) ±72.8 ±53.4 ±232.9 ±306.1 ±8.3 ±61.6 
 
 MRTp (min) 79.3 67.2** 70.1 57.9* 61.3 25.9**
  ±0.8 ±2.2 ±5.5 ±1.8 ±3.5 ±1.7 
 
 MATa (min) 35.6 23.5 26.5 14.3 51.8 16.4
  
 AUCb,f (µg) 1037.8 1115.1 3283.3 3009.6 1566.1 1621.2  
  ±58.9 ±108.0 ±99.9 ±173.4 ±74.9 ±71.1 
 
 AUCb,m (µg) 347.3 534.8 1143.1 1461.0 － －
  ±160.5 ±179.0 ±134.1 ±72.7  
  
 MRTb,f (min) 131.8 112.6* 109.5 88.6* 214.9 192.5
  ±5.5 ±5.9 ±4.9 ±4.1 ±8.0 ±20.1 
 
 MRTb,m (min) 175.7 182.7 113.8 118.9 － － 
  ±16.7 ±29.9 ±5.5 ±8.4 
 
 
     Statistical significance from SI by Student’s t-test (*P < 0.05, ** P < 0.01). 
a MAT (mean absorption time) is the difference of MRTp values between i.v. and i.p. 
administration.   Each value is the mean ± s.e. of at least three experiments. 
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Table 2. Recovery (% of dose) in peritoneal cavity and concentration in liver of 
henol red and bromphenol blue after LS or SI administration in rats. p
 
 Peritoneal cavity (%)   Liver (µg g tissue-1)   
 Drug Site 15 min 60 min 15 min 60 min 
 
 Phenol red SI 57.9 27.2 4.1 4.7 
 (2 mg)  ± 2.6 ± 2.1 ± 0.4 ± 0.2 
 
  LS 49.9* 16.3*  8.3** 10.6** 
   ± 2.4 ± 2.5 ± 0.9 ± 0.8 
 
 Phenol red SI 58.0 27.1 15.1 12.5 
 (6 mg)  ± 2.4 ± 1.1 ± 0.8 ± 2.2 
 
  LS 43.6** 16.9** 26.5** 15.8 
   ± 2.4 ± 1.1 ± 0.2 ± 0.8 
 
 Bromphenol blue SI 63.0 36.7 22.0 31.2 
 (2 mg)  ± 2.4 ± 2.0 ± 2.3 ± 1.8 
 
  LS 47.0** 35.4 33.1** 31.1 
   ± 2.3 ± 1.9 ± 1.6 ± 1.8 
 
 
   Statistical significance from SI by Student’s t-test (*P < 0.05, ** P < 0.01).   
Each value is the mean ± s.e. of at least three experiments. 
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